Role of estrogen receptor-α in the regulation of claudin-6 expression in breast cancer cells

Journal of Breast Cancer

Volumn 14, Issue 1, 2011, Pages 20-27

  Yafang, Liu ^a   Qiong, Wu ^a   Yue, Ren ^a   Xiaoming, Xu ^a   Lina, Yu ^a   Mingzi, Zhang ^a   Ting, Zhang ^a   Yulin, Li ^a   Chengshi, Quan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Breast carcinoma; Claudins; Estrogen; Estrogen receptor alpha; Tight junctions

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; CLAUDIN 6; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION; UPREGULATION; WESTERN BLOTTING;

EID: 79955419692     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2011.14.1.20     Document Type: Article

References (30)

1. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001;2:285-293.
2. Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003;4:225-236.
3. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, et al. Occludin is a functional component of the tight junction. J CellSci 1996;109(Pt9):2287-2298.
4. Lui WY, Lee WM, Cheng CY.Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its efects on occludin, zonula occludens-1, and clau-din-1. Endocrinology 2001;142:1865-1877.
5. Morita K, Furuse M, Fujimoto K, Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA1999;96:511-516.
6. Kramer F, White K, Kubbies M, Swisshelm K, Weber BH. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 2000;107:249-256.
7. Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microar-ray study. Mod Pathol 2005;18:511-518.
8. Oliveira SS, Morgado-Diaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci 2007;64: 17-28.
9. Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, et al. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 2005;11(2Pt1):551-556.
10. Ofner S, Hekele A, Teichmann U, Weinberger S, Gross S, Kufer P et al. Epithelial tight junction proteins as potential antibody targets for pan-carcinoma therapy. Cancer Immunol Immunother 2005;54:431-445.
11. Troy TC, Rahbar R, Arabzadeh A, Cheung RM, Turksen K. Delayed epidermal permeability barrier formation and hair follicle aberrations in Inv-Cldn6 mice. MechDev 2005;122:805-819.
12. Quan C, Lu SJ. Identifcation of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays. Carcinogenesis 2003;24:1593-1599.
13. Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y et al. Tight junction protein, clau-din-6, downregulates the malignant phenotype of breast carcinoma. Eur J Cancer Prev 2010;19:186-194.
14. Osanai M, Murata M, Chiba H, Kojima T, Sawada N. Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci 2007;98:1557-1562.
15. Wu Q, Xu XM, Ren Y, Yu LN, Quan CS, et al. Efects of 17 beta-estradiol on proliferation and migration of MCF- 7 cell by regulating expression of claudin-6. Zhonghua Bing Li Xue Za Zhi 2010;39:44-47.
16. Blanchard AA, Skliris GP, Watson PH, Murphy LC, Penner C, Tomes L, et al. Claudins 1,3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch 2009; 454:647-656.
17. Ye L, Martin TA, Parr C, Harrison GM, Mansel RE, Jiang WG. Biphasic efects of 17-beta-estradiol on expression of occludin and transendo-thelial resistance and paracellular permeability in human vascular endothelial cells. J Cell Physiol 2003;196:362-369.
18. Angelow S, Ahlstrom R, Yu AS. Biology of claudins. Am J Physiol Renal Physiol 2008;295:F867-F876.
19. Blanco D, Vicent S, Elizegi E, Pino I, Fraga MF, Esteller M, et al. Altered expression ofadhesionmolecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab Invest 2004;84:999-1012.
20. Krause G, Winkler L, Mueller SL, Haselof RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta 2008; 1778:631-645.
21. Colegio OR, VanItallie C, Rahner C, Anderson JM. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol 2003; 284:C1346-C1354.
22. Hong YH, Hishikawa D, Myahara H, Nishimura Y, Tsuzuki H, Gotoh C, et al. Up-regulation of the claudin-6 gene in adipogenesis. Biosci Bio-technol Biochem 2005;69:2117-2121.
23. Moriwaki K, Tsukita S, Furuse M. Tight junctions containing claudin 4 and 6 are essential for blastocyst formation in preimplantation mouse embryos. DevBiol 2007;312:509-522.
24. Anderson WJ, Zhou Q, Alcalde V, Kaneko OF, Blank LJ, Sherwood RI, et al. Genetic targeting of the endoderm with claudin-6CreER. Dev Dyn 2008;237:504-512.
25. Tsunoda S, Smith E, De Young NJ, Wang X, Tian ZQ, Liu JF et al. Meth-ylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, andTMEFF2 in esophageal squamous cell carcinoma. Oncol Rep 2009;21:1067-1073.
26. Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, et al. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol 2005;18:26-35.
27. Nilsson S, Makela S, Treuter E, Tujague M, Tomsen J, Andersson G, et al. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-1565.
28. Losel R, Wehling M. Nongenomic actions of steroid hormones. Nat RevMol Cell Biol 2003;4:46-56.
29. Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 1998;76:480-489.
30. O'Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol 2004;18:1859-1875.